Meisner Lara

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Meisner Lara's trades of Bicara Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
186.17
Quantity 36,105
Value US$3,806,956
Transaction date
Proposed sale
Price
167.27
Quantity 64,736
Value US$3,500,364
Transaction date
Proposed sale
Price
11.71
Quantity 33,807
Value US$395,880
Transaction date
Proposed sale
Price
13.35
Quantity 79,146
Value US$1,056,599
Transaction date
Proposed sale
Price
21.16
Quantity 9,375
Value US$198,375
Transaction date
Proposed sale
Price
16.97
Quantity 3,125
Value US$53,031
Transaction date
Proposed sale
Price
24.50
Quantity 12,469
Value US$305,490
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-07 2026-07-07
PrS Proposed sale
36,105
186.17
US$3,806,956 		36,105 186.17 US$3,806,956
2026-06-01 2026-06-01
PrS Proposed sale
64,736
167.27
US$3,500,364 		64,736 167.27 US$3,500,364
2025-10-01 2025-09-29
PlS Planned sale
16,257 +3.3%
57.71
US$2,832,648 		16,257 +3.3% 57.71 US$2,832,648
2025-09-29 2025-09-29
PrS Proposed sale
33,807
11.71
US$395,880 		33,807 11.71 US$395,880
2025-09-17 2025-09-15
PlS Planned sale
15,829 -100.0%
11.49
US$181,875 		15,829 -100.0% 11.49 US$181,875
2025-06-18 2025-06-16
PlS Planned sale
15,829 -100.0%
10.43
US$165,096 		15,829 -100.0% 10.43 US$165,096
2025-06-16 2025-06-16
PrS Proposed sale
31,658
10.84
US$343,173 		31,658 10.84 US$343,173
2025-03-18 2025-03-14
PlS Planned sale
30,620 -100.0%
13.24
US$405,513 		30,620 -100.0% 13.24 US$405,513
2025-03-18 2025-03-14
PlS Planned sale
48,526 -61.3%
12.69
US$615,698 		48,526 -61.3% 12.69 US$615,698
2025-03-14 2025-03-14
PrS Proposed sale
79,146
13.35
US$1,056,599 		79,146 13.35 US$1,056,599
2023-12-18 2023-12-18
PrS Proposed sale
9,375
21.16
US$198,375 		9,375 21.16 US$198,375
2023-12-01 2023-12-01
PrS Proposed sale
3,125
16.97
US$53,031 		3,125 16.97 US$53,031
2023-06-20 2023-06-16
S Sale
27 -0.1%
28.35
US$765 		27 -0.1% 28.35 US$765
2023-06-20 2023-06-15
PlS Planned sale
2,269 -7.0%
28.02
US$63,577 		2,269 -7.0% 28.02 US$63,577
2023-06-06 2023-06-06
S Sale
5,126 -14.6%
25.02
US$128,253 		5,126 -14.6% 25.02 US$128,253
2023-06-06 2023-06-05
S Sale
499 -1.6%
25.03
US$12,490 		499 -1.6% 25.03 US$12,490
2023-06-06 2023-06-02
PlS Planned sale
1,875 -5.9%
24.21
US$45,394 		1,875 -5.9% 24.21 US$45,394
2023-06-02 2023-06-02
PrS Proposed sale
12,469
24.50
US$305,490 		12,469 24.50 US$305,490
2023-03-10 2023-03-09
PlS Planned sale
29,971 -100.0%
29.07
US$871,257 		29,971 -100.0% 29.07 US$871,257
2023-01-25 2023-01-23
PlS Planned sale
6,843 -100.0%
35.66
US$244,021 		6,843 -100.0% 35.66 US$244,021
2022-12-22 2022-12-21
PlS Planned sale
16,326 -100.0%
29.19
US$476,556 		16,326 -100.0% 29.19 US$476,556
2022-12-22 2022-12-20
PlS Planned sale
600 -100.0%
28.07
US$16,842 		600 -100.0% 28.07 US$16,842
2022-12-19 2022-12-16
PlS Planned sale
1,297 -100.0%
28.44
US$36,887 		1,297 -100.0% 28.44 US$36,887
2022-12-19 2022-12-15
PlS Planned sale
300 -100.0%
28.08
US$8,424 		300 -100.0% 28.08 US$8,424
2022-12-14 2022-12-14
PlS Planned sale
15,656 -100.0%
28.12
US$440,247 		15,656 -100.0% 28.12 US$440,247
2022-12-14 2022-12-12
PlS Planned sale
600 -100.0%
28.05
US$16,830 		600 -100.0% 28.05 US$16,830
2022-11-16 2022-11-15
PlS Planned sale
8,125 -100.0%
22.05
US$179,156 		8,125 -100.0% 22.05 US$179,156